Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Ghobrial

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Leukemia|December 8, 2010
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphomaT E Witzig, C B Reeder, B R LaPlant, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Leukemia|March 28, 2017
Proteomic characterization of human multiple myeloma bone marrow extracellular matrixS V Glavey, A Naba, S Manier, et al.
Leukemia|February 10, 2016
Targeting vasculogenesis to prevent progression in multiple myelomaM Moschetta, Y Mishima, Y Kawano, et al.
Leukemia|July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemiaI M Ghobrial, R Redd, P Armand, et al.
Nature Communications|April 29, 2018
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myelomaS Manier, J Park, M Capelletti, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia|December 8, 2010
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphomaT E Witzig, C B Reeder, B R LaPlant, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Leukemia|March 28, 2017
Proteomic characterization of human multiple myeloma bone marrow extracellular matrixS V Glavey, A Naba, S Manier, et al.
Leukemia|February 10, 2016
Targeting vasculogenesis to prevent progression in multiple myelomaM Moschetta, Y Mishima, Y Kawano, et al.
Leukemia|July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemiaI M Ghobrial, R Redd, P Armand, et al.
Nature Communications|April 29, 2018
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myelomaS Manier, J Park, M Capelletti, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
Pageof 2